These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26708315)

  • 1. Multivessel percutaneous coronary intervention without contrast agents.
    Vidi VD; Barseghian A; Garratt KN
    Catheter Cardiovasc Interv; 2016 Dec; 88(7):E222-E226. PubMed ID: 26708315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Karimi Galougahi K; Mintz GS; Karmpaliotis D; Ali ZA
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):E85-E89. PubMed ID: 28303645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.
    Capodanno D; Ministeri M; Cumbo S; Dalessandro V; Tamburino C
    Catheter Cardiovasc Interv; 2014 May; 83(6):907-12. PubMed ID: 23934631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
    Mariani J; Guedes C; Soares P; Zalc S; Campos CM; Lopes AC; Spadaro AG; Perin MA; Filho AE; Takimura CK; Ribeiro E; Kalil-Filho R; Edelman ER; Serruys PW; Lemos PA
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1287-93. PubMed ID: 25326742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in Contrast Nephropathy From Coronary Angiography and Percutaneous Coronary Intervention With Ultra-Low Contrast Delivery Using an Automated Contrast Injector System.
    Kelly SC; Li S; Stys TP; Thompson PA; Stys AT
    J Invasive Cardiol; 2016 Nov; 28(11):446-450. PubMed ID: 27430665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of contrast media on kidney function in patients with stable coronary artery disease.
    Reuter SB; Harutyunyan M; Mygind ND; Jørgensen E; Kastrup J
    Scand Cardiovasc J; 2014 Aug; 48(4):234-40. PubMed ID: 24941300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.
    Lin YS; Fang HY; Hussein H; Fang CY; Chen YL; Hsueh SK; Cheng CI; Yang CH; Chen CJ; Hang CL; Yip HK; Wu CJ
    EuroIntervention; 2014 Feb; 9(10):1173-80. PubMed ID: 24561734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of minimum contrast media volumes during elective percutaneous coronary intervention for prevention of contrast-induced nephropathy in patients with stable coronary artery disease.
    Ebisawa S; Kurita T; Tanaka N; Nasu K; Kimura M; Ito T; Kinoshita Y; Tsuchikane E; Terashima M; Suzuki T
    Cardiovasc Interv Ther; 2016 Jan; 31(1):13-20. PubMed ID: 26001976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention.
    Zhang JY; Wang Q; Wang RT; Li F; Cheng HX; Lian K; Liu Y; Tao L
    BMC Cardiovasc Disord; 2019 Jul; 19(1):160. PubMed ID: 31269899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel technique for ultra-low contrast administration during angiography or intervention.
    Nayak KR; Mehta HS; Price MJ; Russo RJ; Stinis CT; Moses JW; Mehran R; Leon MB; Kandzari DE; Teirstein PS
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1076-83. PubMed ID: 20146209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of metabolic syndrome on development of contrast-induced nephropathy after elective percutaneous coronary intervention among nondiabetic patients.
    Ozcan OU; Adanir Er H; Gulec S; Ustun EE; Gerede DM; Goksuluk H; Tulunay Kaya C; Erol C
    Clin Cardiol; 2015 Mar; 38(3):150-6. PubMed ID: 25800136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased aortic stiffness predicts contrast-induced nephropathy in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    Uçar H; Gür M; Yildirim A; Börekçi A; Gözükara MY; Seker T; Kaypakli O; Türkoğlu C; Özaltun B; Akyol S; Harbalioğlu H; Sahin DY; Elbasan Z; Çayli M
    Angiology; 2014 Oct; 65(9):806-11. PubMed ID: 24078516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of less-contrast media with clinical factors in elective percutaneous coronary intervention.
    Mukai Y; Sakakura K; Yamamoto K; Taniguchi Y; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H
    Heart Vessels; 2020 Feb; 35(2):143-152. PubMed ID: 31327030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study.
    Kashiyama K; Sonoda S; Muraoka Y; Suzuki Y; Kamezaki F; Tsuda Y; Araki M; Tamura M; Takeuchi M; Abe H; Okazaki M; Fujino Y; Otsuji Y
    Int J Cardiovasc Imaging; 2015 Jun; 31(5):935-45. PubMed ID: 25724567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Treatment of Unprotected Left Main Coronary Bifurcation Lesion Using Minimum Contrast Volume with Intravascular Ultrasound Guidance.
    Lee OH; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2017 Sep; 58(5):1066-1070. PubMed ID: 28792156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of intravascular ultrasound-guided minimum-contrast coronary intervention on 1-year clinical outcomes in patients with stage 4 or 5 advanced chronic kidney disease.
    Sakai K; Ikari Y; Nanasato M; Umetsu H; Okutsu M; Takikawa T; Sumitsuji S; Sadamatsu K; Takada M; Kato Y; Ogasawara N; Otowa K
    Cardiovasc Interv Ther; 2019 Jul; 34(3):234-241. PubMed ID: 30343351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency-domain optical coherence tomography assessment of unprotected left main coronary artery disease-a comparison with intravascular ultrasound.
    Fujino Y; Bezerra HG; Attizzani GF; Wang W; Yamamoto H; Chamié D; Kanaya T; Mehanna E; Tahara S; Nakamura S; Costa MA
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E173-83. PubMed ID: 23359350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention causes increase of serum cystatin C concentration even in the patients with a low risk of contrast-induced nephropathy.
    Tanaga K; Tarao K; Nakamura Y; Inoue T; Jo K; Ishikawa T; Miyazaki A
    Cardiovasc Interv Ther; 2012 Sep; 27(3):168-73. PubMed ID: 22692693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.